Rifampicin is a semi-synthetic compound made from rifamycin $\mathrm{B}$, an antibiotic isolated from Streptomyces mediterranei. Rifampicin is an approved antimycobacterial drug that is a standard component of combination regimens for treating tuberculosis and staphylococci infections that resist penicillin. Recent studies have suggested than rifampicin-resistant tuberculosis is becoming more common. For example, $2 \%$ of samples from a survey in Botswana were found to be resistant to the drug. The table below gives some results from wild type $E$. coli and $E$. coli with a single amino acid change in the $\beta$ subunit of RNA polymerase (Asp to Tyr at amino
acid position 516) and their growth response to media that
contained rifampicin. (Severinov, K., Soushko, M., Goldfarb, A., and Nikiforov, V. (1993). Rifampicin region revisited. J. Biol. Chem. 268:14820-14825). (a) What is your interpretation of the data?
(b) What role does the subunit have in RNA
polymerase?
(c) Describe one mechanism for rifampicin-resistant
bacteria.